Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

59Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The concentrations of urinary type plasminogen activator (u-PA), plasminogen activator inhibitor 1 (PAI-1), and PAI-2 were measured in gastric cancer tissues and adjacent healthy mucosal tissues. Levels of u-PA, PAI-1 and PAI-2 were higher in cancer than in control tissues. PAI-1 levels were higher together with the progression of cancer however there were no differences in u-PA or PAI-2 levels. Tumors with higher PAI-1 and lower PAI-2 levels tend to metastasize to remote lymph nodes. When the numbers of involved lymph nodes were analyzed, tumors with the large number of metastatic lymph nodes showed higher PAI-1 and lower PAI-2 level. No difference was shown in u-PA levels among these groups. These tendencies were more significant in patients with progressed gastric cancer. These results suggest that tumor with higher PAI-2 levels tend to localize or have less tendency to metastasize to lymph nodes. On the other hand PAI-1 was generally higher in tumor with invasion into nearby tissue or with nodal metastasis. © 1992.

Cite

CITATION STYLE

APA

Nakamura, M., Konno, H., Tanaka, T., Maruo, Y., Nishino, N., Aoki, K., … Takada, A. (1992). Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thrombosis Research, 65(6), 709–719. https://doi.org/10.1016/0049-3848(92)90110-V

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free